文献速递生殖医学产科

冻融胚胎移植中改良自然周期与人工周期的产科和新生儿风险比较

Increased obstetric and neonatal risks in artificial cycles for frozen embryo transfers?
PubMed 文献 · Reprod Biomed Online · 2021-02-01

本研究为荷兰ANTARCTICA随机对照试验(RCT,NTR 1586)的随访研究,该试验已显示改良自然周期冻融胚胎移植(NC-FET)在活产率方面不劣于人工周期冻融胚胎移植(AC-FET)。本研究收集了98例单胎活产妇女的产科和新生儿结局数据,按符合方案原则分析其中82例,发现两组出生体重无显著差异,改良NC-FET组妊娠期高血压疾病风险低于AC-FET组。

要点

  • 改良NC-FET组妊娠期高血压疾病风险显著低于AC-FET组(RR 0.27,95%CI 0.08-0.94,P=0.031)。
  • 两组出生体重无显著差异(均数差-124 g,95%CI -363至114 g,P=0.30)。
  • 早产、妊娠期糖尿病、产科出血及新生儿结局在两组间无显著差异。

核心结论

  • 改良NC-FET在有排卵周期妇女的冻融胚胎移植中是优选方案,因AC-FET存在产科并发症增加及潜在新生儿并发症的风险。

研究设计与样本

  • 荷兰ANTARCTICA随机对照试验(NTR 1586)的随访研究,共纳入98例单胎活产妇女,按符合方案原则分析82例。

主要发现

  • 两组出生体重无显著差异(均数差-124 g,95%CI -363至114 g,P=0.30)。
  • 改良NC-FET组妊娠期高血压疾病风险低于AC-FET组(相对风险0.27,95%CI 0.08-0.94,P=0.031)。
  • 早产率、妊娠期糖尿病、产科出血及新生儿结局(Apgar评分、新生儿病房或新生儿重症监护病房入住、先天畸形)在两组间无显著差异。

临床怎么用

  • 对于有排卵周期接受冻融胚胎移植的妇女,考虑AC-FET产科并发症风险增加,改良NC-FET可作为优选方案。

局限性

  • 本研究为RCT随访研究,仅分析82例单胎活产数据,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What are the obstetric and neonatal risks for women conceiving via frozen-thawed embryo transfer (FET) during a modified natural cycle compared with an artificial cycle method. DESIGN: A follow-up study to the ANTARCTICA randomized controlled trial (RCT) (NTR 1586) conducted in the Netherlands, which showed that modified natural cycle FET (NC-FET) was non-inferior to artificial cycle FET (AC-FET) in terms of live birth rates. The current study collected data on obstetric and neonatal outcomes of 98 women who had a singleton live birth. The main outcome was birthweight; additional outcomes included hypertensive disorder of pregnancy, premature birth, gestational diabetes, obstetric haemorrhage and neonatal outcomes including Apgar scores and admission to the neonatal ward or the neonatal intensive care unit and congenital anomalies. RESULTS: Data from 82 out of 98 women were analysed according to the per protocol principle. There was no significant difference in the birthweights of children born between groups (mean difference -124 g [-363 g to 114 g]; P = 0.30). Women who conceived by modified NC-FET have a decreased risk of hypertensive disorders of pregnancy compared with AC-FET (relative risk 0.27; 95% CI 0.08-0.94; P = 0.031). Other outcomes, such as rates of premature birth, gestational diabetes or obstetric haemorrhage and neonatal outcomes, were not significantly different. CONCLUSIONS: The interpretation is that modified NC-FET is the preferred treatment in women with ovulatory cycles undergoing FET when the increased risk of obstetrical complications and potential neonatal complications in AC-FET are considered.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Zaat TR, Brink AJ, de Bruin JP, et al. Increased obstetric and neonatal risks in artificial cycles for frozen embryo transfers? Reprod Biomed Online. 2021. PMID: 33736993. doi:10.1016/j.rbmo.2021.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。